Why the study?
Does Roux-en-Y gastric bypass reduce activation of the NLRP3 inflammasome in metabolically active adipose tissue of obese rats?
Population
16 Sprague-Dawley rats with diet-induced obesity, hyperglycemia, and insulin resistance established by 12…
Comparison
Roux-en-Y gastric bypass (RYGB) surgery vs Sham surgery control
Design
Preclinical, randomized into a control sham-operated, or RYGB surgery group
Follow-up
90 days
Authors
Loading...
RYGB may reduce adipose NLRP3 activation in obese rats; translation to human metabolic outcomes remains untested.
Does Roux-en-Y gastric bypass reduce activation of the NLRP3 inflammasome in metabolically active adipose tissue of obese rats?
Bariatric surgery reverses inflammation in visceral adipose tissue by suppressing NLRP3 inflammasome activation in a rat model of diet-induced obesity.
Mocanu et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: